Medium materiality6/10
GoodRx price target raised to $4 from $3 at Barclays
Why it may matterVerify against the original reporting
Moderate upside potential
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Barclays raises GoodRx target to $4 from $3; current price $3.56.
- Analyst: Barclays
- Target: $4
- Posted price: $3.56
Key facts
- 01
Target: $4
- 02
Posted price: $3.56
- 03
Analyst firm: Barclays
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.